Clinical Efficacy of Cefixime for the Treatment of Early Syphilis.
Treponema pallidum
cefixime
early syphilis
penicillin
syphilis
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
07 09 2021
07 09 2021
Historique:
received:
11
12
2020
pubmed:
1
3
2021
medline:
23
9
2021
entrez:
28
2
2021
Statut:
ppublish
Résumé
Safe and efficacious alternative treatment options for syphilis are necessary. This randomized, 2-arm, noncomparative pilot study evaluated the efficacy of oral cefixime 400 mg in achieving a ≥4-fold rapid plasma reagin titer decrease by 3 or 6 months after treatment. The proportion of cefixime arm participants treated successfully was 87% (95% confidence interval, 69%-100%; 13/15). Clinical Trials Registration. NCT03752112.
Identifiants
pubmed: 33640982
pii: 6152217
doi: 10.1093/cid/ciab187
pmc: PMC8423500
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cefixime
97I1C92E55
Banques de données
ClinicalTrials.gov
['NCT03752112']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
907-910Subventions
Organisme : AIDS Healthcare Foundation
ID : 20181796
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.